Differences in adverse events were more marked than differences in efficacy when comparing 32 different antipsychotics, according to findings from a large network meta-analysis published in The Lancet.

Although the results showed that all antipsychotic medications reduced overall symptoms more than placebo, antipsychotics often scored worse for adverse event outcomes, with different profiles.